EP Patent

EP0717992A2 — Aqueous suspension formulations for pharmaceutical applications

Assigned to Kenvue Brands LLC · Expires 1996-06-26 · 30y expired

What this patent protects

The invention features an aqueous pharmaceutical suspension and methods of making same. The suspension comprises a therapeutic amount of controlled release acetaminophen powder, the powder being suspended in a suspending system comprising a suspension stabilizing effective amount…

USPTO Abstract

The invention features an aqueous pharmaceutical suspension and methods of making same. The suspension comprises a therapeutic amount of controlled release acetaminophen powder, the powder being suspended in a suspending system comprising a suspension stabilizing effective amount of xanthan gum, hydroxyethyl cellulose and pregelatinized starch, an effective amount of taste masking composition, and water.

Drugs covered by this patent

Patent Metadata

Patent number
EP0717992A2
Jurisdiction
EP
Classification
Expires
1996-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Kenvue Brands LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.